We are live on ! Find out more
PBM icon

Psyence Biomedical

10 hedge funds and large institutions have $2.34M invested in Psyence Biomedical in 2026 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

366% more capital inflows, than outflows

Capital inflows: $567K | Capital outflows: $122K

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

11% more funds holding

Funds holding: 9 → 10 (+1)

2.76% more ownership

Funds ownership: 9.66% → 12.42% (+2.8%)

Holders
10
Holders Change
+1
Holders Change %
+11.11%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

PBM Hedge Fund Activity: Q3 2026 in Review

10 of the 8,184 institutional investors tracked by Wall St. Rank reported a position in Psyence Biomedical (PBM) for Q3 2026, worth a combined $2.34M — up 88% from $1.24M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new PBM positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 2 trimmed.

The largest buyer was AdvisorShares Investments, adding an estimated $558K. The largest seller was Jane Street, cutting an estimated $58.1K.

  • 10 institutional investors held Psyence Biomedical (PBM) as of Q3 2026, up from 9 in Q2 2026.
  • Funds reported $2.34M of Psyence Biomedical stock for Q3 2026, up 88% quarter-over-quarter.
  • 2 funds opened new Psyence Biomedical positions in Q3 2026 and 1 closed out, a net change of +1 holder.
  • The largest Psyence Biomedical buyer in Q3 2026 was AdvisorShares Investments, an estimated $558K added.
  • The largest Psyence Biomedical seller in Q3 2026 was Jane Street, an estimated $58.1K sold.

Based on aggregated 13F filings for Q3 2026.